ISOVUE 370 is a Intravenous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Bracco Diagnostics Inc. The primary component is Iopamidol.
Product ID | 0270-1316_01b4c288-3a85-406e-9c0a-bc801f85ed52 |
NDC | 0270-1316 |
Product Type | Human Prescription Drug |
Proprietary Name | ISOVUE 370 |
Generic Name | Iopamidol |
Dosage Form | Injection, Solution |
Route of Administration | INTRAVENOUS |
Marketing Start Date | 2014-06-20 |
Marketing Category | NDA / NDA |
Application Number | NDA020327 |
Labeler Name | Bracco Diagnostics Inc |
Substance Name | IOPAMIDOL |
Active Ingredient Strength | 755 mg/mL |
Pharm Classes | Radiographic Contrast Agent [EPC],X-Ray Contrast Activity [MoA] |
NDC Exclude Flag | N |
Listing Certified Through | 2021-12-31 |
Marketing Start Date | 2014-06-20 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA018735 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 1985-12-31 |
Marketing End Date | 2011-09-29 |
Marketing Category | NDA |
Application Number | NDA018735 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | ML |
Marketing Start Date | 1985-12-31 |
Marketing Category | NDA |
Application Number | NDA018735 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 1985-12-31 |
Marketing End Date | 2011-09-29 |
Marketing Category | NDA |
Application Number | NDA020327 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | ML |
Marketing Start Date | 2014-06-20 |
Marketing Category | NDA |
Application Number | NDA020327 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | ML |
Marketing Start Date | 2014-06-20 |
Marketing Category | NDA |
Application Number | NDA018735 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | ML |
Marketing Start Date | 1985-12-31 |
Marketing End Date | 2016-12-31 |
Marketing Category | NDA |
Application Number | NDA018735 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 1985-12-31 |
Marketing End Date | 2011-09-29 |
Marketing Category | NDA |
Application Number | NDA018735 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | ML |
Marketing Start Date | 1985-12-31 |
Marketing Category | NDA |
Application Number | NDA020327 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | ML |
Marketing Start Date | 1994-10-12 |
Marketing Category | NDA |
Application Number | NDA018735 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | ML |
Marketing Start Date | 1985-12-31 |
Marketing Category | NDA |
Application Number | NDA018735 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | ML |
Marketing Start Date | 1985-12-31 |
Marketing Category | NDA |
Application Number | NDA020327 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | ML |
Marketing Start Date | 1994-10-12 |
Marketing Category | NDA |
Application Number | NDA018735 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | ML |
Marketing Start Date | 1985-12-31 |
Marketing Category | NDA |
Application Number | NDA018735 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 1985-12-31 |
Marketing End Date | 2011-09-29 |
Ingredient | Strength |
---|---|
IOPAMIDOL | 755 mg/mL |
SPL SET ID: | 797a11d7-dcd4-43ff-311b-3b48a10da2f2 |
Manufacturer | |
UNII |
NDC | Brand Name | Generic Name |
---|---|---|
76381-316 | ISOVUE 370 | ISOVUE 370 |
0270-1314 | ISOVUE | IOPAMIDOL |
0270-1315 | ISOVUE | IOPAMIDOL |
0270-1316 | ISOVUE | IOPAMIDOL |
0270-1317 | ISOVUE | IOPAMIDOL |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
ISOVUE 85423219 4243227 Dead/Cancelled |
Centrix, Inc. 2011-09-15 |
ISOVUE 75239760 2132582 Dead/Cancelled |
BRACCO DIAGNOSTICS, INC. 1997-02-07 |
ISOVUE 73299442 1237972 Live/Registered |
E. R. Squibb & Sons, Inc. 1981-02-25 |